Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis.
Ayse L MindikogluCristian CoarfaAntone R OpekunVijay H ShahJuan P ArabKonstantinos N LazaridisNagireddy PutluriChandrashekar R AmbatiMatthew J RobertsonSridevi DevarajPrasun K JalalAbbas RanaJohn A GossThomas C DowlingMatthew R WeirStephen L SeligerJean-Pierre RaufmanDavid W BernardJohn M VierlingPublished in: Future science OA (2019)
Plasma metabolites have the potential to enhance the accuracy of mortality predictions, minimize underestimates of mortality in patients with cirrhosis and low MELD-Na scores, and promote equitable allocation of donor livers.